Real-world data from the STEP, SURMOUNT, SUSTAIN, and SURPASS trials shows clear patterns: weight loss is fastest in the first 20 weeks, slows after 40 weeks, and approaches a plateau by 60 to 68 weeks for semaglutide and 72 weeks for tirzepatide
Caution is especially important in people with a history of pancreatitis, significant gastrointestinal disease, severe dehydration risk, certain endocrine tumor syndromes, or medication regimens that may interact with appetite-suppressing or glucose-lowering therapies
We take the time to understand your unique needs and create customized treatment plans that deliver the results you want while supporting your overall wellness
How often do I need to inject a GLP-1 receptor agonist
The body's own GLP-1 plays several important roles in regulating blood glucose and appetite